These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12094558)

  • 21. Tiagabine-induced stupor - more evidence for an encephalopathy.
    Hamandi K; Myers J; Muthukumaraswamy S
    Epilepsy Behav; 2014 Feb; 31():196-7. PubMed ID: 24440890
    [No Abstract]   [Full Text] [Related]  

  • 22. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient.
    Mangano S; Cusumano L; Fontana A
    Brain Dev; 2003 Oct; 25(7):518-21. PubMed ID: 13129597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gabapentin and propofol for treatment of status epilepticus in acute intermittent porphyria.
    Pandey CK; Singh N; Bose N; Sahay S
    J Postgrad Med; 2003; 49(3):285. PubMed ID: 14597800
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypothesis that tiagabine-induced NCSE is associated with GABAergic hyperfunction, with GABA(B) receptors playing a critical role, is supported by a case of generalized NCSE induced by baclofen.
    Solomon GE; Labar D
    Epilepsia; 1998 Dec; 39(12):1383. PubMed ID: 9860080
    [No Abstract]   [Full Text] [Related]  

  • 26. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.
    Shinnar S; Berg AT; Treiman DM; Hauser WA; Hesdorffer DC; Sackellares JC; Leppik I; Sillanpaa M; Sommerville KW
    Epilepsia; 2001 Mar; 42(3):372-9. PubMed ID: 11442155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy.
    Petroff OA; Rothman DL; Behar KL; Lamoureux D; Mattson RH
    Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-convulsive status epilepticus associated with tiagabine therapy in children.
    Skardoutsou A; Voudris KA; Vagiakou EA
    Seizure; 2003 Dec; 12(8):599-601. PubMed ID: 14630501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiagabine-induced stupor in patients with psychogenic nonepileptic seizures: nonconvulsive status epilepticus or encephalopathy?
    Azar NJ; Bangalore-Vittal N; Arain A; Abou-Khalil BW
    Epilepsy Behav; 2013 May; 27(2):330-2. PubMed ID: 23524471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and EEG findings in complex partial status epilepticus with tiagabine.
    Trinka E; Moroder T; Nagler M; Staffen W; Löscher W; Ladurner G
    Seizure; 1999 Feb; 8(1):41-4. PubMed ID: 10091848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in tiagabine serum concentration with coadministration of gemfibrozil.
    Burstein AH; Boudreau EA; Theodore WH
    Ann Pharmacother; 2009 Feb; 43(2):379-82. PubMed ID: 19193595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy.
    Jette N; Cappell J; VanPassel L; Akman CI
    Neurology; 2006 Oct; 67(8):1514-5. PubMed ID: 17060592
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate and other anticonvulsants for psychiatric disorders.
    Med Lett Drugs Ther; 2000 Dec; 42(1094):114-5. PubMed ID: 11114842
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiagabine overdose: a case of status epilepticus in a non-epileptic patient.
    Fulton JA; Hoffman RS; Nelson LS
    Clin Toxicol (Phila); 2005; 43(7):869-71. PubMed ID: 16440516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile].
    Kellinghaus C; Loddenkemper T; Weitemeyer L; Lüdemann P
    Nervenarzt; 2001 Oct; 72(10):764-9. PubMed ID: 11688177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticonvulsant hypersensitivity syndrome: an entity to be remembered].
    Crespo Pérez L; Moreira Vicente V; Cano Ruiz A; Gobernado Serrano JM; Cobo Ibañez N; Milicua Salamero JM
    Gastroenterol Hepatol; 2009 Dec; 32(10):687-92. PubMed ID: 19732994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gabapentin abuse in inmates with prior history of cocaine dependence.
    Reccoppa L; Malcolm R; Ware M
    Am J Addict; 2004; 13(3):321-3. PubMed ID: 15370954
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in the medical treatment of epilepsy.
    Bazil CW; Pedley TA
    Annu Rev Med; 1998; 49():135-62. PubMed ID: 9509255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.